Electron Ionization of Imidazole and Its Derivative 2-Nitroimidazole.
Appearance energy
Electron ionization
Gas phase
Imidazole
Nitroimidazole
Transition state
Unimolecular dissociation
Journal
Journal of the American Society for Mass Spectrometry
ISSN: 1879-1123
Titre abrégé: J Am Soc Mass Spectrom
Pays: United States
ID NLM: 9010412
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
10
05
2019
accepted:
08
09
2019
revised:
02
08
2019
pubmed:
2
11
2019
medline:
1
5
2020
entrez:
1
11
2019
Statut:
ppublish
Résumé
Imidazole (IMI) is a basic building block of many biologically important compounds. Thus, its electron ionization properties are of major interest and essential for the comparison with other molecular targets containing its elemental structure. 2-Nitroimidazole (2NI) contains the imidazole ring together with nitrogen dioxide bound to the C2 position, making it a radiosensitizing compound in hypoxic tumors. In the present study, we investigated electron ionization of IMI and 2NI and determined the mass spectra, the ionization energies, and appearance energies of the most abundant fragment cations. The experiments were complemented by quantum chemical calculations on the thermodynamic thresholds and potential energy surfaces, with particular attention to the calculated transition states for the most important dissociation reactions. In the case of IMI, substantially lower threshold values (up to ~ 1.5 eV) were obtained in the present work compared to the only available previous electron ionization study. Closer agreement was found with recent photon ionization values, albeit the general trend of slightly higher values for the case of electron ionization. The only exception for imidazole was found in the molecular cation at m/z 40 which is tentatively assigned to the quasi-linear HCCNH
Identifiants
pubmed: 31667709
doi: 10.1007/s13361-019-02337-w
pii: 10.1007/s13361-019-02337-w
pmc: PMC6914720
doi:
Substances chimiques
Imidazoles
0
Ions
0
Nitroimidazoles
0
imidazole
7GBN705NH1
azomycin
K8E96XL55D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2678-2691Subventions
Organisme : Austrian Science Fund FWF
ID : P 30332
Pays : Austria
Organisme : Austrian Science Fund (FWF)
ID : P30332
Références
Curr Mol Med. 2009 May;9(4):442-58
pubmed: 19519402
Oncologist. 2004;9 Suppl 5:31-40
pubmed: 15591420
J Chem Phys. 2012 Sep 21;137(11):114303
pubmed: 22998258
J Phys Chem A. 2018 Apr 26;122(16):4031-4041
pubmed: 29652141
J Phys Chem A. 2013 Feb 28;117(8):1756-64
pubmed: 23388058
J Mass Spectrom. 2017 Nov;52(11):770-776
pubmed: 28763569
J Phys Chem A. 2005 Dec 22;109(50):11504-14
pubmed: 16354041
Curr Med Chem Anticancer Agents. 2003 Sep;3(5):364-74
pubmed: 12871083
J Chem Phys. 2005 Sep 8;123(10):104308
pubmed: 16178598
Nat Rev Cancer. 2011 Apr;11(4):239-53
pubmed: 21430696
Angew Chem Int Ed Engl. 2014 Nov 3;53(45):12240-3
pubmed: 25224248
Transl Oncol. 2011 Aug;4(4):189-98
pubmed: 21804913
Eur J Cancer. 2009 May;45(8):1352-69
pubmed: 19153039
J Phys Chem B. 2015 Jan 8;119(1):238-56
pubmed: 25516011
J Phys Chem A. 2019 Apr 11;123(14):3074-3079
pubmed: 30807166
Nature. 1958 Oct 4;182(4640):952-3
pubmed: 13590191
Basic Life Sci. 1991;58:287-317; discussion 317-21
pubmed: 1811474
Curr Probl Cancer. 2001 Nov-Dec;25(6):334-411
pubmed: 11740469
Phys Chem Chem Phys. 2014 Dec 7;16(45):25039-53
pubmed: 25327785
J Phys Chem A. 2019 May 9;123(18):4068-4073
pubmed: 30995841
J Phys Chem A. 2015 Oct 1;119(39):9986-95
pubmed: 26344652
Radiat Res. 2007 Apr;167(4):475-84
pubmed: 17388699
Nature. 1957 Nov 30;180(4596):1191-2
pubmed: 13483652
Chemistry. 2017 Sep 18;23(52):12892-12899
pubmed: 28695572
Phys Chem Chem Phys. 2015 May 21;17(19):12598-607
pubmed: 25899156
Phys Chem Chem Phys. 2017 Mar 1;19(9):6406-6415
pubmed: 28198894
Radiat Res. 1976 Jul;67(1):9-20
pubmed: 940937
Transl Oncol. 2012 Apr;5(2):66-71
pubmed: 22496921
J Chem Phys. 2016 Nov 21;145(19):191102
pubmed: 27875881